Special Populations in Clinical Trials

Summary

This practice note explains key regulatory and compliance considerations for clinical trials involving the following special populations of research subjects identified in federal regulations: pregnant women, human fetuses, neonates, prisoners, and children. In addition, this practice note discusses steps that pharmaceutical, medical device, and other life sciences companies may need to take to minimize risks to these special populations.